# A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers

> **NCT02429232** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Osteoporosis
- Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Linagliptin

## Key facts

- **NCT ID:** NCT02429232
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2017-07
- **Final completion:** 2017-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2015-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02429232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02429232, "A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02429232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*